On 25 June 2018, the Kenya National TB, Leprosy and Lung Disease Program (NLTP) launched the TB isolation policy as a result of over seven years of litigation, advocacy and follow up by people with TB, affected communities, civil society organisations, and human rights lawyers.
The policy outlines procedures to be followed when admitting persons with TB who interrupt or refuse to take their TB medication. It emphasizes the use of a patient-centred approach during the entire course of treatment, whilst spelling out the rights and responsibilities of people with TB. The policy also articulates factors to be taken into account before enforcement of isolation.
The news release about the launch is available here with some background information around the case.
Source: KELIN